Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1

Status

Completed 24Unknown 10Recruiting 7Withdrawn 4Terminated 4Active not recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 3Genitourinary 1

Conditions

Multiple Myeloma 2Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Neoplasms, Plasma Cell 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Simvastatin × Clear all
NCT02971410 2018-07-02

Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Withdrawn
Plasma cell

Multiple Myeloma

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

University of Louisville

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01561482 2015-07-22

Study of Metformin With Simvastatin for Men With Prostate Carcinoma

Baylor College of Medicine

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT00503763 2015-04-16

PSMMSS

Meir Medical Center

Phase 2 Withdrawn
Plasma cell

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡